STOCK TITAN

Johnson Controls International plc Form 4 Filings

JCI NYSE

Every Form 4 that Johnson Controls International plc (JCI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow JCI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full JCI filings page.

Rhea-AI Summary

Johnson Controls International plc reported a new equity award to its Executive Vice President & General Counsel. On 12/01/2025, the officer acquired 4,785 ordinary shares at a price of $0, described as restricted share units that, subject to acceleration and forfeiture provisions, vest in three equal installments on December 7, 2026, December 7, 2027 and December 7, 2028. Following this grant, the officer beneficially owns 33,662.391 ordinary shares directly.

The filing also shows a grant of an employee stock option covering 18,290 ordinary shares with an exercise price of $114.94 per share. Subject to certain conditions, half of these options become exercisable on December 7, 2027 and the remaining half on December 7, 2028, with an expiration date of December 1, 2035. The restricted share units accrue dividend equivalents and convert into ordinary shares upon vesting, providing long-term, performance-linked compensation.

Rhea-AI Summary

Johnson Controls International plc reported a routine equity award to a senior executive. On December 1, 2025, the company granted 4,404 restricted share units, which are scheduled to vest in three equal installments on December 7, 2026, December 7, 2027, and December 7, 2028, and convert into ordinary shares upon vesting. The filing also discloses a grant of 16,835 employee stock options with an exercise price of $114.94 per share, half of which become exercisable on December 7, 2027 and the other half on December 7, 2028, with an expiration date of December 1, 2035. Following these grants, the reporting officer directly holds 63,314.55 ordinary shares and 16,835 stock options.

Rhea-AI Summary

Johnson Controls International plc (JCI) executive VP & President, Global Products reported a sale of company stock in a Form 4 filing. On 11/21/2025, the reporting person sold 32,031 ordinary shares of JCI at a weighted average price of $113.20 per share, with individual trade prices ranging from $112.61 to $113.55. After this transaction, the insider beneficially owns 66,780.5 ordinary shares, held directly. The filing notes that detailed trade-by-trade pricing information within the reported range is available upon request from the issuer, any security holder, or the SEC staff.

Rhea-AI Summary

Johnson Controls International plc (JCI) reported an insider transaction by a company officer on Form 4. The reporting person, an officer serving as VP, President Global Field Ops, filed as a single reporting person. On 11/18/2025, this officer disposed of 5,384 ordinary shares of JCI at a price of $114.44 per share. Following this transaction, the officer beneficially owned 58,910.55 ordinary shares, held in direct ownership. The filing shows no derivative security transactions, as the derivative securities table contains no entries.

Rhea-AI Summary

Johnson Controls International plc (JCI) reported a change in insider holdings by a company officer. On 11/14/2025, the VP & President, Global Products reported a disposition of 16,408 ordinary shares at a price of $118.72 per share. After this transaction, the reporting person directly beneficially owns 98,811.5 ordinary shares of JCI. The filing is made on Form 4 by a single reporting person, reflecting their role as an officer of the company.

Rhea-AI Summary

Johnson Controls International plc (JCI) reported an insider transaction by a director. On 11/13/2025, the director made a bona fide gift (Code G) of 4,890 ordinary shares at $0. After this transaction, the director beneficially owned 9,987.63 shares, held directly.

Rhea-AI Summary

Johnson Controls International (JCI): insider transaction

The company’s VP & President, Global Products, reported selling 10,500 ordinary shares on 11/06/2025 at a weighted average price of $122.03. Following the sale, the officer directly holds 115,219.5 shares. The filing notes the sale occurred across multiple trades between $121.78 and $122.35.